Latest News and Press Releases
Want to stay updated on the latest news?
-
Delhi, May 26, 2023 (GLOBE NEWSWIRE) -- Global Controlled Release Drug Delivery Market Opportunity, Drug Pricing & Clinical Trials Insight 2028 Report Overview: Controlled Release Drug...
-
Delhi, May 24, 2023 (GLOBE NEWSWIRE) -- China Cancer Antibodies Market Trends & Clinical Trials Insight 2023 Report Highlights: China Cancer Antibodies (Monoclonal, Bispecific, Trispecific,...
-
Delhi, May 24, 2023 (GLOBE NEWSWIRE) -- Global SYK Inhibitors Market, Drug Price, Sales & Clinical Trials Outlook 2028 Report Highlights: Global SYK Inhibitors Market Current & Forecast...
-
Delhi, May 24, 2023 (GLOBE NEWSWIRE) -- Global VISTA Inhibitor Clinical Trials & Market Opportunity Insight 2023 Report Highlights: Market Potential Of VISTA InhibitorsMarket...
-
Delhi, May 12, 2023 (GLOBE NEWSWIRE) -- Global Bispecific Antibody Market Opportunity & Clinical Trials Insight 2023 Report Highlights: Global Market Yearly & Quarterly Sales Insight (2018...
-
Delhi, May 03, 2023 (GLOBE NEWSWIRE) -- China Cancer Antibodies Market Trends & Clinical Trials Insight 2023 Report Highlights: China Cancer Antibodies (Monoclonal, Bispecific, Trispecific,...
-
Delhi, April 27, 2023 (GLOBE NEWSWIRE) -- PD-1 and CTLA-4 were the first immune checkpoints that were used as therapeutic targets by drug makers. Years later, a new generation of immune checkpoint...
-
Delhi, April 27, 2023 (GLOBE NEWSWIRE) -- Tifcemalimab also known as TAB004 and JS004 is the world’s first in human recombinant humanized anti- BTLA (B and T lymphocyte attenuator) monoclonal...
-
Delhi, April 27, 2023 (GLOBE NEWSWIRE) -- Global Dopamine Cell Replacement Therapy Clinical Trials, Companies & Market Trends Insight 2023 Report Highlights: Research MethodologyGlobal Market...
-
Delhi, April 24, 2023 (GLOBE NEWSWIRE) -- Immune checkpoints play an important role in the regulation of the immune response against antigens under normal conditions. However, in cases when the...